Be in the know. 10 key reads for Friday…

  1. The Stock Market Doesn’t Need Another Stimulus Bill. Really. (Barron’s)
  2. Dr. Scott Gottlieb: Remdesivir best coronavirus treatment should Trump need one (CNBC)
  3. Trian Fund Management takes 9.9% stakes in Invesco, Janus Henderson (CNBC)
  4. The McLaren GT is out of this world in style and performance (USA Today)
  5. White House doctor says Trump can carry out duties without disruption (MarketWatch)
  6. Why US evangelicals are flocking to Trump (Financial Times)
  7. Roblox Plans To Go Public Via IPO Or Direct Listing: Report (Benzinga)
  8. President of One of Largest Dominican Republic Private Health Systems: Ivermectin has Helped Treat 6,000 Patients (TrialSiteNews)
  9. Wall Street’s Biggest Banks Are Muscling Into Small Deals (Bloomberg)
  10. Even in a Rough Patch, Some Energy Stocks Offer Attractive Yield (Barron’s)

Be in the know. 10 key reads for Thursday…

  1. Why Star Of Magic Lance Burton Thinks Practice Doesn’t Make Perfect (Investor’s Business Daily)
  2. The Stock Market Had an Awful September. Here’s What History Says Happens Next. (Barron’s)
  3. Regeneron’s Good News on Covid Antibodies Is Positive for Vaccines, Too (Barron’s)
  4. Ford cuts price of 2021 Mustang Mach-E: Here’s the breakdown (USA Today)
  5. The US economy doesn’t need more fiscal stimulus for a V-shaped recovery, veteran strategist Ed Yardeni says (Business Insider)
  6.  New Proteomics Analysis May Show How Ivermectin Fights COVID-19 (TrialSiteNews)
  7. Trump Could Get His Vaccine Before Election Day (Bloomberg)
  8. China’s Economic Rebound Picks Up Pace (Wall Street Journal)
  9. Cézanne, Picasso and a T. Rex—This Auction Season, Anything Goes (Wall Street Journal)
  10. Value Stocks Are Outperforming Growth—at Least for Now (Wall Street Journal)